Found: 8
Select item for more details and to access through your institution.
Population Pharmacokinetics of Tofacitinib in Patients With Moderate to Severe Ulcerative Colitis.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 3, p. 229, doi. 10.1002/cpdd.899
- By:
- Publication type:
- Article
Rapid Sample Size Calculations for a Defined Likelihood Ratio Test-Based Power in Mixed-Effects Models.
- Published in:
- AAPS Journal, 2012, v. 14, n. 2, p. 176, doi. 10.1208/s12248-012-9327-8
- By:
- Publication type:
- Article
Sparse item testing of clinical scales in neurology trials to alleviate burden to patients.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 10, p. 6847, doi. 10.1007/s00415-024-12650-4
- By:
- Publication type:
- Article
Modeling of Survival and Frequency of Cardiovascular-Related Hospitalization in Patients with Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis.
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 5, p. 535, doi. 10.1007/s40256-021-00464-y
- By:
- Publication type:
- Article
Tofacitinib pharmacokinetics in children and adolescents with juvenile idiopathic arthritis.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 4, p. 599, doi. 10.1002/psp4.13104
- By:
- Publication type:
- Article
Development of a model‐based clinical trial simulation platform to optimize the design of clinical trials for Duchenne muscular dystrophy.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 3, p. 318, doi. 10.1002/psp4.12753
- By:
- Publication type:
- Article
Estimands—What they are and why they are important for pharmacometricians.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2021, v. 10, n. 4, p. 279, doi. 10.1002/psp4.12617
- By:
- Publication type:
- Article
Towards regulatory endorsement of drug development tools to promote the application of model-informed drug development in Duchenne muscular dystrophy.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2019, v. 46, n. 5, p. 441, doi. 10.1007/s10928-019-09642-7
- By:
- Publication type:
- Article